Rights Commence Trading

Matthew Wygant Investor Updates

Imagion Biosystems Limited (ASX: IBX) (the Company), is pleased to confirm that the rights associated with the Company’s Renounceable Rights Issue announced on 28 October 2019 have commenced trading on a deferred basis under the ASX ticker IBXR.

Under the Rights Issue timetable the rights trading will end on 8 November 2019.

Read Rights Commence Trading.